Yannick Vanloubbeeck | Head of Immunology
GSK

WVIC/WAC Day 2 - Nov 30 @ 09:00

Global Health Goals – can we get back on track?

• How has the pandemic affected the status of the epidemics of tuberculosis, malaria and neglected tropical diseases?
• Silver linings – new investments in immunization infrastructure – understanding of barriers and opportunities in promoting vaccination within communities and countries. How do we try to capitalize on some of the new pathways generated because of covid?
• How will malaria vaccines be implemented? How does this vaccine need to be promoted differently to previous vaccines? How to communicate value of vaccines in burdened communities. Integrated strategy required.
• TB vaccines how are we moving forward? Next steps for TB vaccines.

Steven Reed, Chief Executive Officer, HDT Bio Corp

×

Steven Reed / Global Health Goals – can we get back on track?

Steven Reed, Chief Executive Officer,
HDT Bio Corp

Steve Reed is the co-founder, President, and CEO of HDT Bio, based in Seattle, USA. His academic appointments include Adjunct Professor of Medicine at Cornell University Medical College Research Professor of Pathobiology at the University of Washington. Dr. Reed received a PhD in Microbiology and...

CloseMore

Yannick Vanloubbeeck, Head of Immunology, GSK

×

Yannick Vanloubbeeck / Global Health Goals – can we get back on track?

Yannick Vanloubbeeck, Head of Immunology,
GSK

Yannick Vanloubbeeck (DVM, PhD) is Head of Immunology at GSK Vaccines R&D, based in Belgium. He has joined GSK Vaccines in 2006 to lead the preclinical development of vaccine candidates against diseases of the developing world, including malaria & tuberculosis. In his current role he is...

CloseMore

Ashley Birkett, Global Head, Malaria Vaccines and Biologics, PATH

×

Ashley Birkett / Global Health Goals – can we get back on track?

Ashley Birkett, Global Head, Malaria Vaccines and Biologics,
PATH

Ashley Birkett is the Global Head of Malaria within PATH’s Center for Vaccine Innovation and Access (CVIA) and serves on the CVIA Leadership Team. CVIA brings together expertise across every stage of vaccine research, development, and introduction to make vaccines globally available to...

CloseMore

Alison Kraigsley, Program Officer, TB Vaccines, The Bill & Melinda Gates Foundation

×

Alison Kraigsley / Global Health Goals – can we get back on track?

Alison Kraigsley, Program Officer, TB Vaccines,
The Bill & Melinda Gates Foundation

Alison Kraigsley is the TB Vaccines Program Officer at the Bill and Melinda Gates Foundation and is responsible for developing and managing a portfolio of research investments to address scientific gaps and support the development of a robust TB vaccine pipeline. Alison has a broad background in...

CloseMore